Syngene International Limited Share Price & Technical Analysis
SYNGENE · ₹465.3 (+0.62%)
Healthcare / Diagnostics & Research
₹465.3
+0.62%
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analy…
Price chart
Seasonality
May has 2 positive and 3 negative years (last 5 years shown)
-1% return in May, 2% avg return in past 3 year May month.
-25% return in 2026, 6% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -27% | -10% | -6% | 18% | -1% | – | – | – | – | – | – | – | -25% |
| 25 | -13% | -12% | 12% | -12% | 2% | 0% | 12% | -12% | 0% | 4% | -1% | 0% | -21% |
| 24 | 7% | -6% | -1% | -2% | -3% | 4% | 14% | 8% | 3% | -4% | 9% | -9% | 21% |
| 23 | -4% | 1% | 2% | 13% | 7% | 5% | 4% | -3% | 4% | -15% | 11% | -7% | 19% |
| 22 | -8% | -6% | 10% | 6% | -8% | -3% | 3% | 6% | -6% | 12% | -4% | -4% | -1% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Uptrend
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States of America, Europe, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinical development services. It provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical studies, biometrics and clinical data management, central lab, regulatory, medical monitoring, pharmacovigilance, and medical writing services. In addition, the company offers chemistry, biology, safety assessment, computational, and data sciences for traditional small molecule therapeutics; biologics; and specialty modalities, such as peptides, oligonucleotides, antibody-drug conjugates, and targeted degradation/stabilization. It serves pharmaceutical, biotechnology, animal health, nutrition, consumer goods, agrochemical, performance and specialty materials, and other companies. The company has collaborations with Bristol-Myers Squibb, Baxter Inc., and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹192.39B
P/E ratio
54.84
52W high
₹728.6
52W low
₹380.0
Volume
3,83,160
Beta
0.03
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Syngene International Limited share price today?
- Syngene International Limited (SYNGENE) last traded around ₹465.3 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SYNGENE have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SYNGENE. Download the app for real-time alerts.
- How can I analyze Syngene International Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.